|
RNA Amplification Just Got Better: MessageAmp II
• Compatible with
GeneChip® analysis
• Amplify as little
as 100 ng RNA in a single round
• Includes the
new ArrayScript engineered M-MLV RT, engineered
to maximize yields of full- length cDNA
• cRNA synthesis
powered by MEGAscript®, the best in vitro
transcription technology
• Consistently
delivers high percent Present Calls and low 3'/5' ratios
in GeneChip analysis
Gene arrays simultaneously measure the expression
levels of thousands of genes in a single experiment and have
become the most widely used method for assessing gene expression
on a genome wide scale. The primary limitation of this technology
is the requirement for large amounts of RNA for array hybridization.
This is especially a problem when working with limited samples,
such as small biopsies, mRNA-deficient cells and tissues, primary
cell cultures, and laser capture microdissection (LCM) samples.
This hurdle is usually overcome by using T7 RNA polymerase driven
transcription of cDNA obtained from total RNA samples to generate
sufficient amounts of amplified antisense or copy RNA (aRNA or
cRNA). This amplification method is commonly referred to as the "Eberwine
method" [1], "IVT method" or the "aRNA or cRNA method".
Ambion's new MessageAmp
II aRNA Amplification Kit (patent pending) incorporates extensive improvements to the
original MessageAmp aRNA Amplification Kit. Improving amplification
involves more than simply increasing the final yield of labeled
cRNA. Consistency with other amplification methods is also important
so data can be compared across methods. Microarray expression
profiling data from MessageAmp II and the Affymetrix recommended
protocol for GeneChip™ analysis (see sidebar, Obtain
Reproducible Microarray Data) show a high level of concordance.
The new MessageAmp II Kit provides a wide dynamic range of RNA
input (100 pg-5 µg), and a single round of amplification
on samples as small as 100 ng generates sufficient cRNA for GeneChip
analysis.
Improved Yields of Full-length cDNA
Even before developing MessageAmp II,
it was apparent that the efficiencies of the reverse transcription
step and the second strand cDNA synthesis reaction were critical
for generating high yields of labeled cRNA with minimal change
to the representation of message abundance in total RNA samples.
This observation led to further optimization of the second
strand cDNA synthesis reaction and the development of ArrayScript™,
an M-MLV reverse transcriptase specifically engineered to generate
high yields of full-length cDNA.
Higher Quality cDNA. Ambion's
new ArrayScript produces higher yields of full-length cDNA
compared to other reverse transcriptases (Figure 1). Figure
2 demonstrates that up to twice as much cRNA is synthesized
when first-strand cDNA is generated with ArrayScript compared
to wild type M-MLV, AMV, or other engineered M-MLV reverse
transcriptases when low amounts of total RNA are used (~100
ng). This improved performance may eliminate the need for two
rounds of cRNA amplification when working with small samples,
thus reducing reagent cost and reaction time.
Second-strand cDNA Synthesis. The
second-strand cDNA synthesis reaction has also been optimized
specifically for the first-strand cDNA products generated with
ArrayScript. This results in maximal conversion of first-strand
cDNA into full-length double-stranded cDNA templates, thus
increasing the average length of cRNA synthesized using MessageAmp
II.
|
Figure 1. ArrayScript Reverse
Transcriptase Synthesizes Intact cDNA Products as Long
as 9 kb. cDNA
synthesis was performed with 100 U of either ArrayScript
RT, SuperScript II (SSII), SuperScript III
(SSIII), or wild type (wt) M-MLV RT in a 20 µl
reaction volume containing a synthetic, poly(A)-tailed
9 kb transcript (1 µg), 1X RT buffer, 0.5 µM
oligo(dT) primer, 0.5 mM dNTPs, 40 U RNase Inhibitor,
and 0.1 µl [α-32P]dATP. Reactions were
incubated for 1 hr at 42ºC and quenched with EDTA.
The cDNA products were resolved on a 1% denaturing
agarose gel and detected with a phosphorimager. |
| |
|
Figure 2. ArrayScript Reverse Transcriptase Produces up to Twice the aRNA
Yield in MessageAmp II. A
comparison of ArrayScript RT (AS; 200 U), SuperScript
II (SSII; 200 U); wild type M-MLV RT (200 U), and wild
type AMV RT (10 U) in MessageAmp II conditions demonstrates
that ArrayScript outperforms other commercial RTs.
90 ng HeLa-S3 total RNA (28S/18S ratio = 1.7) was heat
denatured in the presence of T7 Oligo(dT) at 70°C
for 10 minutes. Reverse transcription was initiated
with the RT enzyme and incubated at 42ºC for 2
hr in an air incubator. Following first strand cDNA
synthesis, DNA polymerase was added for second strand
synthesis, which was incubated at 16ºC for 2 hr
in a thermocycler (heated lid option turned off). The
double-stranded cDNA was then filter purified and added
to a 4 hr in vitro transcription reaction. Last, the
resulting aRNA was purified by glass filter and eluted
in nuclease-free water for analysis by Agilent 2100
bioanalyzer and NanoDrop® Spectrophotometer. |
An Improved Amplification Kit
The RT and second-strand cDNA synthesis
improvements, combined with the use of MEGAscript technology
in the in vitro transcription reaction (IVT) result in the
ability to use shortened IVT incubation times, and the generation
of expression information from total RNA samples <1 µg.
In two round amplification reactions, the MessageAmp II Kit
facilitates robust amplification of total RNA from samples
as low as 100 pg.
The MessageAmp II aRNA Amplification
Kit contains all the necessary reagents for first-strand cDNA
synthesis, RNase H digestion, second-strand synthesis, cDNA
purification, in vitro transcription and aRNA purification.
Reagents for 20 reactions and a detailed Instruction Manual
are included.
| back to sidebar |
|
|
|
Figure 3. Replicate
Analysis of Two Amplification Protocols. Normalized
array results are plotted from replicate amplifications.
Both MessageAmp II (top) and Affymetrix® standard
protocol (bottom) were used to amplify with the identical
total RNA samples (1 µg), and equivalent amounts
of cRNA were hybridized on matched lot Human Genome
Focus arrays. All IVT reactions were performed for
4 hours. Correlation values are included and indicate
a measure of reproducibility with both methods.
|
|
Ordering Information for Ambion Products:
|
| Cat# |
Product Name |
Size |
| AM1751 |
MessageAmp™ II aRNA Amplification Kit |
20 rxns |
| For Research Use Only. Not for use in diagnostic procedures. |
|
| TechNotes
Archive |
| Ordering
Information |
|
Array Analysis: The Basics [read]
|
Master Mix Calculators for MessageAmp™-type Kits [read]
|
Tips for Successful RNA Amplification [read]
|
|
|
To evaluate the consistency of the MessageAmp II
protocol, duplicate 1 µg samples of either human brain
RNA, or HeLa S3 cell RNA (HeLa) were amplified using the MessageAmp
II Kit. The cRNA produced was hybridized to Affymetrix® GeneChip® Human
Genome Focus Arrays following the manufacturer's guidelines.
As a reference, 1 µg of the same RNA samples were amplified
using the Affymetrix GeneChip 3'-Amplification Reagents One-Cycle
cDNA Synthesis Kit and IVT Labeling Reagents (from here on
referred to as the Affymetrix protocol). Again, the resulting
cRNA was hybridized to GeneChip Human Genome Focus Arrays following
the manufacturer's guidelines. The Affymetrix quality assessment
guidelines were met for all arrays in this study. This included
3'/5' ratios (under 2.0), percent Present Calls (50-53%),
scaling factors, average background, as well as visual inspection
of images. This assessment indicated that all array hybridizations
were of high quality.
Signal values for each probe set were
converted from .CEL files into a summary of expression values
for each of the 8793 probe sets (genes). Expression
values were estimated using Robust Multi-array Average (RMA) [2-4] as
implemented in BioConductor. The results are shown in
Figure 3. We found that array results using MessageAmp II amplified RNA from
both brain and HeLa cells were very reproducible, with correlation values of
0.998 and 0.997 respectively in this experiment. The Affymetrix protocol gave
similar results; correlation values were 0.996 and 0.992 between the brain
and HeLa replicates.
A number of other microarray experiments were
conducted to compare the MessageAmp II Kit to the Affymetrix
protocol on a variety of different criteria including correspondence
of replicates, Present/Absent Call Concordance, the effect of
IVT incubation times on microarray signal characteristics, and
expression analysis at low RNA inputs. Furthermore, we have assessed
the concordance of data generated with the new MessageAmp II
Kit to that generated with the original MessageAmp Kit. [View
data]
|
|
1. Van Gelder RN, von Xastrow
ME, Yool A, Dement DC, Barchas JD, Eberwine JH (1990) Amplified
RNA synthesized from limited quantities of heterogeneous cDNA. Proc
Natl Acad Sci USA87: 1663-7.
2. Bolstad BM, Irizarry RA, Astrand
M, Speed TP (2003) A comparison of normalization methods
for high density oligonucleotide array data based on variance
and bias. Bioinformatics 19: 185-93.
3. Irizarry RA, Bolstad BM, Collin
F, Cope LM, Hobbs B, Speed TP (2003) Summaries of Affymetrix
GeneChip probe level data. Nucl Acids Res 31(4):e15.
4. Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration,
normalization, and summaries of high density oligonucleotide
array probe level data. Biostatistics 4:249-64.
|
|